MNKD Mannkind Corp

Price (delayed)

$5.99

Market cap

$1.39B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.21

Enterprise value

$1.46B

Sector: Healthcare
Industry: Biotechnology

MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, its ...

Highlights

Mannkind's gross profit has increased by 14% from the previous quarter and by 3.5% YoY
Mannkind's EPS has increased by 13% YoY
Mannkind's net income has increased by 4.9% YoY but it has decreased by 2% from the previous quarter
Mannkind's quick ratio has decreased by 45% QoQ and by 36% YoY
The equity has declined by 3.7% since the previous quarter

Key stats

What are the main financial stats of MNKD
Market
Shares outstanding
232.6M
Market cap
$1.39B
Enterprise value
$1.46B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
21.94
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23.35
Earnings
Revenue
$62.69M
EBIT
-$35.97M
EBITDA
-$32.61M
Free cash flow
-$33.88M
Per share
EPS
-$0.21
Free cash flow per share
-$0.15
Book value per share
-$0.81
Revenue per share
$0.27
TBVPS
$0.42
Balance sheet
Total assets
$95.68M
Total liabilities
$282.1M
Debt
$123.35M
Equity
-$186.42M
Working capital
-$39.78M
Liquidity
Debt to equity
-0.66
Current ratio
0.63
Quick ratio
0.54
Net debt/EBITDA
-2.17
Margins
EBITDA margin
-52%
Gross margin
59.5%
Net margin
-71.9%
Operating margin
-46.2%
Efficiency
Return on assets
-48.4%
Return on equity
N/A
Return on invested capital
-39.1%
Return on capital employed
N/A
Return on sales
-57.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MNKD stock price

How has the Mannkind stock price performed over time
Intraday
13.45%
1 week
8.71%
1 month
69.21%
1 year
294.08%
YTD
91.37%
QTD
91.37%

Financial performance

How have Mannkind's revenue and profit performed over time
Revenue
$62.69M
Gross profit
$37.32M
Operating income
-$28.94M
Net income
-$45.09M
Gross margin
59.5%
Net margin
-71.9%
MNKD's operating income is up by 38% YoY and by 20% QoQ
MNKD's operating margin is up by 38% year-on-year and by 21% since the previous quarter
Mannkind's gross profit has increased by 14% from the previous quarter and by 3.5% YoY
Mannkind's gross margin has increased by 12% QoQ and by 4% YoY

Growth

What is Mannkind's growth rate over time

Valuation

What is Mannkind stock price valuation
P/E
N/A
P/B
N/A
P/S
21.94
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23.35
Mannkind's EPS has increased by 13% YoY
The equity has declined by 3.7% since the previous quarter
The P/S is 168% higher than the 5-year quarterly average of 8.2

Efficiency

How efficient is Mannkind business performance
The company's return on invested capital fell by 32% QoQ
Mannkind's ROS has decreased by 11% from the previous quarter but it has increased by 2.2% YoY

Dividends

What is MNKD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNKD.

Financial health

How did Mannkind financials performed over time
The company's total assets is 66% lower than its total liabilities
Mannkind's quick ratio has decreased by 45% QoQ and by 36% YoY
The company's current ratio fell by 41% QoQ and by 34% YoY
The company's debt is 166% higher than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.